Literature DB >> 25956504

The Pharmacokinetics and Tissue Distribution of Honokiol and its Metabolites in Rats.

Wang Jun-Jun1, Miao Xiao-Lei1, Chen Jing-Ya1, Chen Yong2.   

Abstract

Honokiol (HK) is the main bioactive compound isolated from the bark of Magnolia officinalis. The present work is the first to report the pharmacokinetics and distribution of HK and its two metabolites of hydroxylated HK conjugated with glucuronic and sulfuric acid (M1) and HK monoglucuronide (M2) in plasma, liver, kidney and brain following oral administration of HK (40 mg/kg) to healthy Wistar rats. The results showed that only HK but not M1 or M2 was found in brain. Additionally, our work indicated that M2 not HK was the major compound in liver and plasma. The elimination of HK in liver, kidney and brain, and M2 in liver and kidney was more rapid than in plasma. The finding suggested that some of the pharmacological activity of HK might be generated by M2 but not HK.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 25956504     DOI: 10.1007/s13318-015-0281-6

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  21 in total

1.  Pharmacokinetics of honokiol after intravenous guttae in beagle dogs assessed using ultra-performance liquid chromatography-tandem mass spectrometry.

Authors:  Yi Liang; Gang Cui; Xiaoxue Wang; Wei Zhang; Quan An; Zongtao Lin; Hong Wang; Shizhong Chen
Journal:  Biomed Chromatogr       Date:  2014-03-21       Impact factor: 1.902

Review 2.  Roles of glucuronidation and UDP-glucuronosyltransferases in xenobiotic bioactivation reactions.

Authors:  J K Ritter
Journal:  Chem Biol Interact       Date:  2000-12-01       Impact factor: 5.192

3.  Comparison of antioxidant abilities of magnolol and honokiol to scavenge radicals and to protect DNA.

Authors:  Chao Zhao; Zai-Qun Liu
Journal:  Biochimie       Date:  2011-06-23       Impact factor: 4.079

4.  Honokiol induces apoptosis through p53-independent pathway in human colorectal cell line RKO.

Authors:  Tao Wang; Fei Chen; Zhe Chen; Yi-Feng Wu; Xiao-Li Xu; Shu Zheng; Xun Hu
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

5.  Effects of honokiol and magnolol on acute and inflammatory pain models in mice.

Authors:  Yi-Ruu Lin; Hwei-Hsien Chen; Chien-Hsin Ko; Ming-Huan Chan
Journal:  Life Sci       Date:  2007-08-19       Impact factor: 5.037

6.  Characterization, pharmacokinetics, tissue distribution and antitumor activity of honokiol submicron lipid emulsions in tumor-burdened mice.

Authors:  Jiaxin Zheng; Yujie Tang; Moran Sun; Yuanyuan Zhao; Qiang Li; Jie Zhou; Yanzhi Wang
Journal:  Pharmazie       Date:  2013-01       Impact factor: 1.267

7.  Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo.

Authors:  Xianhe Bai; Francesca Cerimele; Masuko Ushio-Fukai; Muhammad Waqas; Paul M Campbell; Baskaran Govindarajan; Channing J Der; Traci Battle; David A Frank; Keqiang Ye; Emma Murad; Wolfgang Dubiel; Gerald Soff; Jack L Arbiser
Journal:  J Biol Chem       Date:  2003-06-19       Impact factor: 5.157

8.  Honokiol is a potent scavenger of superoxide and peroxyl radicals.

Authors:  Sergey Dikalov; Tanya Losik; Jack L Arbiser
Journal:  Biochem Pharmacol       Date:  2008-07-02       Impact factor: 5.858

9.  Intravenous administration of Honokiol provides neuroprotection and improves functional recovery after traumatic brain injury through cell cycle inhibition.

Authors:  Haiquan Wang; Zhengbu Liao; Xiaochuan Sun; Quanhong Shi; Gang Huo; Yanfeng Xie; Xiaolan Tang; Xinggang Zhi; Zhaohua Tang
Journal:  Neuropharmacology       Date:  2014-06-25       Impact factor: 5.250

10.  Pharmacokinetics of honokiol after intravenous administration in rats assessed using high-performance liquid chromatography.

Authors:  T H Tsai; C J Chou; F C Cheng; C F Chen
Journal:  J Chromatogr B Biomed Appl       Date:  1994-04-22
View more
  4 in total

1.  Inhibition of Rat CYP1A2 and CYP2C11 by Honokiol, a Component of Traditional Chinese Medicine.

Authors:  Jing Li; Ming-Rui Li; Bao Sun; Cheng-Ming Liu; Jing Ren; Wen-Qian Zhi; Pei-Yu Zhang; Hai-Ling Qiao; Na Gao
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2019-12       Impact factor: 2.441

2.  Honokiol inhibits carotid artery atherosclerotic plaque formation by suppressing inflammation and oxidative stress.

Authors:  Yuan Liu; Peng Cheng; An-Hua Wu
Journal:  Aging (Albany NY)       Date:  2020-05-04       Impact factor: 5.682

Review 3.  Honokiol: A Review of Its Anticancer Potential and Mechanisms.

Authors:  Chon Phin Ong; Wai Leong Lee; Yin Quan Tang; Wei Hsum Yap
Journal:  Cancers (Basel)       Date:  2019-12-22       Impact factor: 6.639

4.  Effectiveness in the Block by Honokiol, a Dimerized Allylphenol from Magnolia Officinalis, of Hyperpolarization-Activated Cation Current and Delayed-Rectifier K+ Current.

Authors:  Ming-Huan Chan; Hwei-Hsien Chen; Yi-Ching Lo; Sheng-Nan Wu
Journal:  Int J Mol Sci       Date:  2020-06-15       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.